Literature DB >> 9213250

Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables.

S Takamatsu1, H Nakabayashi, Y Okamoto, H Nakano.   

Abstract

To evaluate the diagnostic utility of blood biochemical parameters in assessing degree of hepatic fibrosis, serum levels of aminoterminal type III procollagen peptide (P III P), type IV collagen (IV-collagen), 7S domain of type IV collagen (7S-collagen), and hyaluronan (HA) were measured in 54 patients with chronic viral liver disease. Liver collagen content was quantified by a computer-assisted image analysis method. Significant correlations were found between the amount of collagen in the liver and serum levels of P III P (r = 0.482; P < 0.02), IV-collagen (r = 0.705; P < 0.001), 7S-collagen (r = 0.771; P < 0.001), and HA (r = 0.595; P < 0.001). To optimize diagnostic efficacy, we applied multivariate regression analysis to the combined results obtained for these blood biochemical parameters and some additional laboratory tests. The correlation coefficient obtained from the application of this model was 0.809. To measure the predictive value of the proposed model, we used it to estimate collagen content in an additional 16 patients with chronic liver disease and compared the estimated to the actual amount of collagen determined by direct measurement. The correlation coefficient was 0.937. These results suggest that application of the model would be useful for the assessment of collagen content of fibrotic liver.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213250     DOI: 10.1007/bf02934493

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  36 in total

1.  Heterogeneity of antigens related to 7S domain of type IV collagen in serum: application to patients with chronic liver disease.

Authors:  S Yamada; Y Kishimoto; T Suou; H Kawasaki; Y Horie
Journal:  Clin Chim Acta       Date:  1992-11-16       Impact factor: 3.786

2.  Evaluation of fibrosis in the disse space in noncirrhotic alcoholic liver disease.

Authors:  P Robert; B Champigneulle; I Kreher; J L Gueant; B Foliguet; J M Dollet; M A Bigard; P Gaucher
Journal:  Alcohol Clin Exp Res       Date:  1989-04       Impact factor: 3.455

3.  Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage.

Authors:  A Nyberg; A Engström-Laurent; L Lööf
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

4.  Radioimmunoassay of type I collagen that mainly detects degradation products in serum: application to patients with liver diseases.

Authors:  D J Hartmann; J C Trinchet; S Ricard-Blum; M Beaugrand; P Callard; G Ville
Journal:  Clin Chem       Date:  1990-03       Impact factor: 8.327

5.  Increased amount of serum type IV collagen peptide in human liver fibrosis as determined by enzyme-immunoassay with monoclonal antibodies.

Authors:  E Matsumoto; Y Muragaki; A Ooshima
Journal:  Acta Pathol Jpn       Date:  1989-04

6.  A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.

Authors:  A López-De León; M Rojkind
Journal:  J Histochem Cytochem       Date:  1985-08       Impact factor: 2.479

7.  Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases.

Authors:  J Kropf; A M Gressner; A Negwer
Journal:  Clin Chem       Date:  1988-10       Impact factor: 8.327

8.  Clinical significance of the serum levels of the 7S domain of type IV collagen in patients with primary biliary cirrhosis.

Authors:  T Fukutomi; S Sakamoto; H Isobe; H Sakai; A Masumoto; H Nawata
Journal:  J Gastroenterol Hepatol       Date:  1992 Nov-Dec       Impact factor: 4.029

9.  Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease.

Authors:  A Hayasaka; D Schuppan; K Ohnishi; K Okuda; E G Hahn
Journal:  J Hepatol       Date:  1990-01       Impact factor: 25.083

10.  The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease.

Authors:  A Frei; A Zimmermann; K Weigand
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

View more
  7 in total

1.  Correlation between stellate cell activation and serum fibrosis markers in choline-deficient L-amino acid-defined diet-induced rat liver fibrosis.

Authors:  K Hironaka; I Sakaida; K Uchida; K Okita
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

2.  Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Hiroshi Sakugawa; Tomofumi Nakayoshi; Kasen Kobashigawa; Tsuyoshi Yamashiro; Tatsuji Maeshiro; Satoru Miyagi; Joji Shiroma; Akiyo Toyama; Tomokuni Nakayoshi; Fukunori Kinjo; Atsushi Saito
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

Review 3.  Hepatic fibrosis: are any of the serum markers useful?

Authors:  S Oh; N H Afdhal
Journal:  Curr Gastroenterol Rep       Date:  2001-02

4.  The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis.

Authors:  Dai Zhang; Nian-Yue Wang; Cheng-Bao Yang; Guo-Xiang Fang; Wei Liu; Jian Wen; Chan Luo
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

5.  Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.

Authors:  Masato Yoneda; Hironori Mawatari; Koji Fujita; Kyoko Yonemitsu; Shingo Kato; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Yasunobu Abe; Kensuke Kubota; Satoru Saito; Tomoyuki Iwasaki; Yasuo Terauchi; Shinji Togo; Shiro Maeyama; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2007-05-25       Impact factor: 7.527

6.  Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis: A retrospective observational study.

Authors:  Kohei Kotani; Joji Kawabe; Shigeaki Higashiyama; Atsushi Yoshida; Etsushi Kawamura; Akihiro Tamori; Susumu Shiomi; Norifumi Kawada
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression.

Authors:  Kazuya Nagao; Tsukasa Inada; Akinori Tamura; Kenji Kajitani; Kiyotaka Shimamura; Hiroshi Yukawa; Kenji Aida; Naoya Sowa; Masataka Nishiga; Takahiro Horie; Toshinori Makita; Koh Ono; Masaru Tanaka
Journal:  ESC Heart Fail       Date:  2018-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.